Palantir’s year-to-date stock performance.
Palantir: “There is no level that the buyers won’t take this stock higher. So I’m going to tell you that I would hold on to it as a spec and let them walk it up.”
Stanley Black & Decker’s year-to-date stock performance.
Travere Therapeutics’ year-to-date stock performance.
Sign up now for the CNBC Investing Club to follow Jim Cramer’s every move in the market.
Disclaimer The CNBC Investing Club Charitable Trust holds shares of Stanley Black & Decker.
Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Want to take a deep dive into Cramer’s world? Hit him up!
Mad Money Twitter – Jim Cramer Twitter – Facebook – Instagram
Questions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com